Karen Ballack > Weil, Gotshal & Manges LLP > Redwood Shores, United States > Lawyer Profile
Weil, Gotshal & Manges LLP Offices

201 REDWOOD SHORES PARKWAY
REDWOOD SHORES, CA 94065
CALIFORNIA
United States
- Firm Profile
- Go to...
Karen Ballack

Position
Partner
Career
Karen Ballack is an intellectual property transactional attorney with emphasis on representing technology companies, particularly in the computer (hardware and software), Internet, semiconductor, biotechnology, pharmaceutical and medical device industries. Karen is also a member of Weil’s Privacy & Cybersecurity group and is based in the Silicon Valley office. Karen has extensive experience in a wide variety of complex technology and intellectual property alliances and transactions. Representative matters include: licensing arrangements; research and development collaborations; joint ventures; strategic alliances and corporate partnering transactions; intellectual property acquisitions and divestitures; manufacture and supply arrangements; distribution and reseller arrangements; co‑marketing alliances; consulting and professional services agreements; and other arrangements involving the commercial exploitation of technology and intellectual property. Karen’s practice also includes providing intellectual property assistance in connection with private equity, M&A and other corporate transactions. Karen is frequently engaged as a guest speaker on topics relating to technology and intellectual property transactions.
Education
San Diego State University (B.S., summa cum laude, 1981); University of San Francisco (J.D., 1986).
Lawyer Rankings
United States > Media, technology and telecoms > Technology transactions
Weil, Gotshal & Manges LLP has extremely good experience representing companies and investors operating in the technology and life sciences industries. The team has developed good credentials for standalone technology and IP deals, including advice on patent acquisitions and divestitures, licensing arrangements, research and development collaborations, and technology and IP-focused joint ventures and strategic alliances. A recent highlight included advising Eli Lilly and Company on a license agreement to acquire exclusive global rights to antibody-drug conjugates for the targeted treatment of cancer from ImmunoGen. This expertise feeds through into the broader support the team provides to the corporate finance group, including advice on corporate M&A and private equity buyouts, banking and finance transactions, and restructuring matters. Jeffrey Osterman and Charan Sandhu jointly lead the market-leading team, which also includes Karen Ballack in Silicon Valley, and the department’s founder and former head, Michael Epstein. All partners are based in New York unless otherwise stated.
Lawyer Rankings
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Tax > US taxes: non-contentious
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: equity offerings
- Intellectual property > Copyright
- Tax > Financial products
- Tax > International tax
- Labor and employment > Labor and employment disputes (including collective actions)
- Media, technology and telecoms > Media and entertainment: litigation
- M&A/corporate and commercial > Private equity buyouts
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Finance > Structured finance: securitization
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: oil and gas
- Healthcare > Life sciences
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Industry focus > Sport
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trademarks: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense